Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event
affecting patients with cancer and patients with osteoporosis who have been treated with …

Bone physiology relies on the delicate balance between resorption and formation of its
tissue. Bone resorption depends on a process called osteoclastogenesis in which bone …

The Medication-Related Osteonecrosis of Jaws (MRONJ) diagnosis process and its
prevention play a role of great and rising importance, not only on the Quality of Life (QoL) of …

Objective This manuscript aims to provide a comprehensive review of the current knowledge
in the pathophysiology, diagnosis, prevention, and other relevant forensic and clinical …

Objective The main aim is to identify, by means of different imaging modalities, the early
bone changes in patients “at risk” and in stage 0 MRONJ. Materials and methods A search of …

Alendronate (ALN) is a second-generation bisphosphonate widely used for osteoporosis
and cancer-induced bone lesions. Many studies have confirmed a strong relationship …

Objective To investigate the relationship between preoperative trabecular bone structure
and implant outcome based on bone morphometric bone parameters from CBCT scans …

Objectives To investigate the extension of experimentally induced peri-implantitis lesions
under various antiresorptive and antiangiogenic medications. Material and methods Fourty …

Bone mass loss (osteoporosis) seen in postmenopausal women is an adverse factor for
implant denture. Using an ovariectomized rat model, we studied the mechanism of estrogen …

Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a well known side-effect
of anti-resorptive drugs. Changes in bone density might potentially constitute the …